NOTIFICATION OF MAJOR HOLDINGS |
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: |
Spire Healthcare Group PLC |
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) |
Non-UK issuer |
|
2. Reason for the notification (please mark the appropriate box or boxes with an "X") |
An acquisition or disposal of voting rights |
|
An acquisition or disposal of financial instruments |
X |
An event changing the breakdown of voting rights |
|
Other (please specify)iii: |
|
3. Details of person subject to the notification obligationiv |
Name |
The Goldman Sachs Group, Inc. |
City and country of registered office (if applicable) |
Corporation Trust Center, 1209 Orange Street, Wilmington DE 19801, USA |
4. Full name of shareholder(s) (if different from 3.)v |
Name |
|
City and country of registered office (if applicable) |
|
5. Date on which the threshold was crossed or reachedvi: |
04/10/2017 |
6. Date on which issuer notified (DD/MM/YYYY): |
06/10/2017 |
7. Total positions of person(s) subject to the notification obligation |
|
% of voting rights attached to shares (total of 8. A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights of issuervii |
Resulting situation on the date on which threshold was crossed or reached |
1.76% |
1.31% |
3.08% |
401,081,391 |
Position of previous notification (if applicable) |
1.73% |
1.27% |
2.996% |
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii |
|
A: Voting rights attached to shares |
|
Class/type of sharesISIN code (if possible) |
Number of voting rightsix |
% of voting rights |
|
Direct(Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect(Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
Direct(Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect(Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
|
GB00BNLPYF73 |
|
7,068,178 |
|
1.76% |
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8. A |
7,068,178 |
1.76% |
|
|
|
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) |
|
Type of financial instrument |
Expiration datex |
Exercise/ Conversion Periodxi |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights |
|
Securities Lending |
Open |
|
5,266,107 |
1.31% |
|
|
|
|
|
|
|
|
|
SUBTOTAL 8. B 1 |
5,266,107 |
1.31% |
|
|
|
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) |
|
Type of financial instrument |
Expiration datex |
Exercise/ Conversion Period xi |
Physical or cash settlementxii |
Number of voting rights |
% of voting rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8.B.2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|